Issue |
Section |
Title |
File |
Vol 81, No 8 (2009) |
Editorial |
Clinical implications of urine matrix metalloproteinases assay in patients with chronic glomerulonephritis |
|
Vol 82, No 6 (2010) |
Editorial |
New capacities of the diagnosis and monitoring of the course of AL-amyloidosis |
|
Vol 82, No 6 (2010) |
Editorial |
Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho |
|
Vol 83, No 2 (2011) |
Editorial |
An IL-6 level in the serum and urine in estimation of cryoglobulinemic vasculitis activity in patients with chronic hepatitis C associated with renal damage |
|
Vol 83, No 6 (2011) |
Editorial |
Estimation of podocyte dysfunction by nephrinuria severity in proteinuric forms of chronic glomerulonephritis |
|
Vol 83, No 6 (2011) |
Editorial |
Determination of urinary markers of proteolysis/fibrinolysis and fibroangiogenesis in the kidney in hypertensive patients |
|
Vol 83, No 6 (2011) |
Editorial |
The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys |
|
Vol 83, No 8 (2011) |
Editorial |
Current methods of diagnosis and monitoring of a systemic amyloidosis course |
|
Vol 83, No 11 (2011) |
Editorial |
Specific damage to the kidneys in patients with chronic hepatitis C associated with cryoglobulinemia |
|
Vol 84, No 6 (2012) |
Editorial |
MUCKLE-WELLS SYNDROME CAUSED BY A NEW CRYOPIRIN MUTATION: EFFECTIVE TREATMENT WITH INTERLEUKIN-1 ANTAGONIST |
|
Vol 82, No 1 (2010) |
Editorial |
Significance of the markers of endothelial dysfunction and hemorheological disorders for assessing the activity and prognosis of chronic glomerulonephritis |
|
Vol 93, No 6 (2021) |
Original articles |
The analysis of secondary AA-amyloidosis current etiology and its influence on the approaches for diagnosis and treatment |
 (Rus)
|